Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

1.16
Delayed Data
As of May 26
 +0.02 / +1.75%
Today’s Change
1.12
Today|||52-Week Range
11.96
-43.41%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization50.4K47.7K36.2K75.1K
 
 
 
 
 
 
Operating ExpensesGross Income-50.4K-47.7K-36.2K-75.1K
 
 
 
 
 
General Expenses9.4M9.8M15.5M24.0M
 
 
 
 
 
Research And Development5.3M6.0M10.9M19.1M
 
 
 
 
 
Total Operating Expenses9.5M9.9M15.5M24.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.5M-9.9M-15.5M-24.1M
 
 
 
 
 
Extraordinary Credit642.4K529.8K2.9M3.8M
 
 
 
 
 
Interest Expense On Debt----222.8K1.8M
 
 
 
Other Expenses0.00-62.7K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.8M-9.4M-12.8M-22.1M
 
 
 
 
 
Net Income-8.8M-9.4M-12.8M-22.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS1.4M1.5M2.2M2.8M
 
 
 
 
 
Shares To Calculate EPS Diluted1.4M1.5M2.2M2.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$6.40-$6.40-$6.00-$7.89
 
 
 
 
 
EPS Diluted-$6.40-$6.40-$6.00-$7.89